Scott Rasmussen

541 total citations
8 papers, 410 citations indexed

About

Scott Rasmussen is a scholar working on Molecular Biology, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Scott Rasmussen has authored 8 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Scott Rasmussen's work include Biochemical and Molecular Research (2 papers), HIV/AIDS drug development and treatment (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). Scott Rasmussen is often cited by papers focused on Biochemical and Molecular Research (2 papers), HIV/AIDS drug development and treatment (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). Scott Rasmussen collaborates with scholars based in United States, United Kingdom and Denmark. Scott Rasmussen's co-authors include Craig M. Pratt, Steen Juul‐Möller, A. John Camm, Denis Roy, Egon Toft, Ian G. Stiell, James E. Ip, D. George Wyse, Benoit Coutu and Edward L.C. Pritchett and has published in prestigious journals such as Circulation, Antimicrobial Agents and Chemotherapy and British Journal of Clinical Pharmacology.

In The Last Decade

Scott Rasmussen

7 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Rasmussen United States 5 219 135 80 79 45 8 410
Marie‐Noëlle Bizot France 8 221 1.0× 73 0.5× 52 0.7× 55 0.7× 16 0.4× 8 420
Pål Falck Norway 10 94 0.4× 59 0.4× 91 1.1× 23 0.3× 37 0.8× 12 345
Marion Dahlke Switzerland 12 132 0.6× 85 0.6× 37 0.5× 32 0.4× 9 0.2× 31 436
Kristian Bailey United Kingdom 8 88 0.4× 97 0.7× 39 0.5× 64 0.8× 20 0.4× 16 320
Ching‐Ming Yeh United States 13 271 1.2× 55 0.4× 43 0.5× 39 0.5× 10 0.2× 18 466
Regina Sennewald Germany 9 125 0.6× 84 0.6× 44 0.6× 58 0.7× 8 0.2× 13 336
Christine Reynolds United States 11 105 0.5× 92 0.7× 72 0.9× 62 0.8× 18 0.4× 15 420
Stephanie Hesselson Australia 12 96 0.4× 141 1.0× 80 1.0× 22 0.3× 28 0.6× 28 398
E. Worth United Kingdom 8 40 0.2× 202 1.5× 50 0.6× 36 0.5× 58 1.3× 9 347
Camille Lenoir Switzerland 9 51 0.2× 42 0.3× 34 0.4× 83 1.1× 33 0.7× 13 258

Countries citing papers authored by Scott Rasmussen

Since Specialization
Citations

This map shows the geographic impact of Scott Rasmussen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Rasmussen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Rasmussen more than expected).

Fields of papers citing papers by Scott Rasmussen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Rasmussen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Rasmussen. The network helps show where Scott Rasmussen may publish in the future.

Co-authorship network of co-authors of Scott Rasmussen

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Rasmussen. A scholar is included among the top collaborators of Scott Rasmussen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Rasmussen. Scott Rasmussen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Khalilieh, Sauzanne, Ka Lai Yee, Rosa I. Sánchez, et al.. (2019). Doravirine and the Potential for CYP3A-Mediated Drug-Drug Interactions. Antimicrobial Agents and Chemotherapy. 63(5). 21 indexed citations
2.
Rasmussen, Scott, et al.. (2018). Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers. Clinical Pharmacology in Drug Development. 7(5). 506–512. 10 indexed citations
3.
Zhou, Diansong, Karen So, Nidal Al‐Huniti, et al.. (2016). Evaluation of the Effect of Selumetinib on Cardiac Repolarization: A Randomized, Placebo- and Positive-controlled Crossover QT/QTc Study in Healthy Subjects. Clinical Therapeutics. 38(12). 2555–2566. 3 indexed citations
4.
Prueksaritanont, Thomayant, Xiaoyan Chu, Raymond Evers, et al.. (2014). Pitavastatin is a more sensitive and selective organic anion‐transporting polypeptide1Bclinical probe than rosuvastatin. British Journal of Clinical Pharmacology. 78(3). 587–598. 144 indexed citations
5.
Choy, Gavin, et al.. (2012). Safety, tolerability, and pharmacokinetics of amuvatinib from three phase 1 clinical studies in healthy volunteers. Cancer Chemotherapy and Pharmacology. 70(1). 183–190. 6 indexed citations
6.
Rasmussen, Scott, et al.. (2010). Epithelioid Angiosarcoma of the Talus. The Journal of Foot & Ankle Surgery. 50(1). 87–92. 3 indexed citations
7.
Roy, Denis, Craig M. Pratt, Christian Torp‐Pedersen, et al.. (2008). Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation. Circulation. 117(12). 1518–1525. 222 indexed citations
8.
Rasmussen, Scott, et al.. (1983). Systolic time intervals during long-term beta-blockade with alprenol in ischaemic heart disease. European Journal of Clinical Pharmacology. 25(4). 503–506. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026